Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 28, 2022 07:00 ET | Source: BIOXYTRAN, INC.

Crystal Research Update Highlights 100% Responders Rate in Mild to Moderate COVID-19 Trial

Trial meets endpoints in safety and efficacyIND Letter from the CDSCO to optimize dosageEstablishment of an Indian Subsidiary to commercialize ProLectin-M BOSTON, MASSACHUSETTS, Dec. 28,...